Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Wearable Electronic Devices × Clear all

Phase

Status

Sponsor Class

OTHER 7 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 1 Breast Neoplasms 1

Interventions

pembrolizumab 848 Carboplatin 791 Paclitaxel 779 Gemcitabine 649 Cisplatin 627 Docetaxel 600 Bevacizumab 521 Nivolumab 417 Pemetrexed 410 Cyclophosphamide 396 Capecitabine 386 Fluorouracil 333 Dexamethasone 329 Rituximab 328 Oxaliplatin 284 Injections 280 atezolizumab 262 Trastuzumab 257 Cetuximab 237 Leucovorin 227 Irinotecan 216 Prednisone 215 130-nm albumin-bound paclitaxel 213 Doxorubicin 209 Ipilimumab 198 Lenalidomide 193 Fulvestrant 185 fludarabine 177 durvalumab 173 venetoclax 168

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04736576 2024-11-22

JBCRG-26

Pfizer

Phase NA Completed

99 enrolled 47 charts

Breast Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡